GE HealthCare Technologies Inc. $GEHC Shares Acquired by IFP Advisors Inc

IFP Advisors Inc increased its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 27.6% in the second quarter, Holdings Channel reports. The firm owned 12,277 shares of the company’s stock after purchasing an additional 2,657 shares during the period. IFP Advisors Inc’s holdings in GE HealthCare Technologies were worth $936,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds have also recently modified their holdings of the company. Park Avenue Securities LLC increased its holdings in shares of GE HealthCare Technologies by 32.3% during the 1st quarter. Park Avenue Securities LLC now owns 5,887 shares of the company’s stock valued at $475,000 after purchasing an additional 1,437 shares in the last quarter. Farther Finance Advisors LLC lifted its position in shares of GE HealthCare Technologies by 52.7% in the first quarter. Farther Finance Advisors LLC now owns 4,493 shares of the company’s stock valued at $357,000 after acquiring an additional 1,550 shares in the last quarter. GAMMA Investing LLC lifted its holdings in GE HealthCare Technologies by 19.2% in the 1st quarter. GAMMA Investing LLC now owns 9,559 shares of the company’s stock valued at $772,000 after purchasing an additional 1,543 shares in the last quarter. Assenagon Asset Management S.A. boosted its position in GE HealthCare Technologies by 2.4% during the first quarter. Assenagon Asset Management S.A. now owns 12,891 shares of the company’s stock worth $1,040,000 after acquiring an additional 300 shares during the last quarter. Finally, CX Institutional lifted its position in GE HealthCare Technologies by 7.8% during the first quarter. CX Institutional now owns 3,893 shares of the company’s stock worth $314,000 after buying an additional 281 shares in the last quarter. Institutional investors and hedge funds own 82.06% of the company’s stock.

GE HealthCare Technologies Price Performance

GE HealthCare Technologies stock opened at $71.01 on Monday. The company has a debt-to-equity ratio of 0.85, a quick ratio of 0.93 and a current ratio of 1.16. The company has a market cap of $32.42 billion, a price-to-earnings ratio of 14.55, a PEG ratio of 2.71 and a beta of 1.13. The firm has a 50 day moving average price of $74.31 and a 200 day moving average price of $72.22. GE HealthCare Technologies Inc. has a 1 year low of $57.65 and a 1 year high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHC) last released its quarterly earnings data on Wednesday, July 30th. The company reported $1.06 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.91 by $0.15. The company had revenue of $5 billion during the quarter, compared to analyst estimates of $4.96 billion. GE HealthCare Technologies had a net margin of 11.22% and a return on equity of 23.93%. The business’s quarterly revenue was up 3.5% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.00 earnings per share. GE HealthCare Technologies has set its FY 2025 guidance at 4.430-4.630 EPS. Sell-side analysts predict that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.

GE HealthCare Technologies Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 14th. Investors of record on Friday, October 24th will be given a dividend of $0.035 per share. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.2%. The ex-dividend date of this dividend is Friday, October 24th. GE HealthCare Technologies’s dividend payout ratio is currently 2.87%.

Analyst Ratings Changes

GEHC has been the topic of several recent analyst reports. Wall Street Zen lowered GE HealthCare Technologies from a “buy” rating to a “hold” rating in a research note on Saturday, September 20th. BTIG Research reiterated a “buy” rating on shares of GE HealthCare Technologies in a research note on Monday, July 14th. Citigroup cut GE HealthCare Technologies from a “buy” rating to a “neutral” rating and cut their price target for the company from $93.00 to $83.00 in a research note on Tuesday, October 7th. Morgan Stanley set a $74.00 target price on shares of GE HealthCare Technologies in a report on Thursday, September 18th. Finally, Weiss Ratings reaffirmed a “hold (c)” rating on shares of GE HealthCare Technologies in a research report on Saturday, September 27th. Six equities research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $85.78.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.